GlobeNewswire
Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance
📈
AI Sentiment
Highly Positive
8/10
Amgen Inc. News
Latest updates and market news for AMGN
16 news
Mar 6 - Mar 12, 2026
Page 1
Barrons.com
Starbucks, Amgen, and CVS Help This Income Fund Shine
📈
AI Sentiment
Highly Positive
8/10
Cincinnati.com | The Enquirer
GE Aerospace invest $115M in region
📈
AI Sentiment
Highly Positive
8/10
MarketBeat
Amgen Touts 2025 Double-Digit Growth, MariTide Obesity Push and BiTE Momentum at Leerink Conference
📈
AI Sentiment
Highly Positive
10/10
24/7 Wall St.
Josh Brown: Biotech growth stocks immune to disruption risk
📊
AI Sentiment
Positive
6/10
24/7 Wall St.
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street’s Latest Biopharma Calls Explained
📈
AI Sentiment
Highly Positive
9/10
24/7 Wall St.
Here Are Tuesday’s Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims & Hers, Intuit, Lowe’s, Qualcomm, Rivian, Strategy and More
📊
AI Sentiment
Positive
6/10
Simply Wall St.
Assessing Whether Amgen (AMGN) Shares Look Mispriced After Recent Mixed Returns
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Amgen Oncology Advances Test Dividend Strength And Long Term Growth Story
📈
AI Sentiment
Highly Positive
9/10
Investor's Business Daily
Stock Market Today: Dow Gains As Trump Says Iran War Is 'Very Complete'; Cruise Stock Soars (Live Coverage)
📊
AI Sentiment
Positive
7/10
Zacks
Take the Zacks Approach to Beat the Markets: Starbucks, Amgen, Allogene in Focus
📉
AI Sentiment
Negative
3/10
StockStory
Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks
📈
AI Sentiment
Highly Positive
9/10
Pharma Voice
The first KRAS drugs have been sluggish on the market. Will the next generation fare better?
📊
AI Sentiment
Positive
6/10
Insider Monkey
Amgen Inc. (AMGN) Completes Phase 3 Trial for ABP 206 Opdivo Biosimilar Candidate
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
Illumina Regeneron Alliance Targets Multiomics And Raises Valuation Questions
📊
AI Sentiment
Positive
7/10
Share this news page